CA1340672C - Derives de la cephalosporine - Google Patents

Derives de la cephalosporine

Info

Publication number
CA1340672C
CA1340672C CA000616144A CA616144A CA1340672C CA 1340672 C CA1340672 C CA 1340672C CA 000616144 A CA000616144 A CA 000616144A CA 616144 A CA616144 A CA 616144A CA 1340672 C CA1340672 C CA 1340672C
Authority
CA
Canada
Prior art keywords
amino
compound
formula
mixture
thiadiazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000616144A
Other languages
English (en)
Inventor
Takayuki Naito
Jun Okumura
Masahisa Oka
Haruhiro Yamashida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of CA1340672C publication Critical patent/CA1340672C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA000616144A 1984-04-09 1991-08-21 Derives de la cephalosporine Expired - Fee Related CA1340672C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09
US597,941 1984-04-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000615909A Division CA1340609C (fr) 1984-04-09 1990-10-25 Derives de la cephalosporine

Publications (1)

Publication Number Publication Date
CA1340672C true CA1340672C (fr) 1999-07-20

Family

ID=24393575

Family Applications (3)

Application Number Title Priority Date Filing Date
CA000474260A Expired - Lifetime CA1276929C (fr) 1984-04-09 1985-02-14 Agents antibacteriens de cephalosporine
CA000616143A Expired - Fee Related CA1340638C (fr) 1984-04-09 1991-08-12 Derives de la cephalosporine
CA000616144A Expired - Fee Related CA1340672C (fr) 1984-04-09 1991-08-21 Derives de la cephalosporine

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CA000474260A Expired - Lifetime CA1276929C (fr) 1984-04-09 1985-02-14 Agents antibacteriens de cephalosporine
CA000616143A Expired - Fee Related CA1340638C (fr) 1984-04-09 1991-08-12 Derives de la cephalosporine

Country Status (31)

Country Link
JP (4) JPS615084A (fr)
KR (1) KR870002166B1 (fr)
AR (1) AR244694A1 (fr)
AT (1) AT388735B (fr)
AU (2) AU580990B2 (fr)
BE (1) BE902148A (fr)
CA (3) CA1276929C (fr)
CH (1) CH669197A5 (fr)
DD (3) DD236735A5 (fr)
DE (1) DE3512225A1 (fr)
DK (1) DK155985A (fr)
ES (4) ES8607318A1 (fr)
FI (1) FI84830C (fr)
FR (1) FR2563832B1 (fr)
GB (3) GB2157293B (fr)
GR (1) GR850883B (fr)
HU (2) HU204277B (fr)
IE (2) IE58408B1 (fr)
IL (1) IL74826A (fr)
IT (1) IT1190353B (fr)
LU (1) LU85840A1 (fr)
MY (1) MY101940A (fr)
NL (1) NL192925C (fr)
NZ (1) NZ211659A (fr)
OA (1) OA07985A (fr)
PT (1) PT80246B (fr)
RU (1) RU2056425C1 (fr)
SE (4) SE466205B (fr)
SU (4) SU1367858A3 (fr)
YU (2) YU46151B (fr)
ZA (1) ZA852236B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
WO1987003875A1 (fr) * 1985-12-26 1987-07-02 Eisai Co., Ltd. Derives de cephalosporine
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 3−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
DE68929368T2 (de) * 1988-03-16 2002-08-14 Eisai Co., Ltd. Cephemderivate und Verfahren zu ihrer Herstellung
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
KR100248851B1 (ko) * 1994-08-16 2000-04-01 이치로 키타사토 신규 세펨 유도체
JP4033630B2 (ja) 1998-06-22 2008-01-16 バジリア ファルマスーチカ アーゲー プロペニルセファロスポリン誘導体
EP1666483B1 (fr) 2003-09-09 2011-08-17 Nippon Chemical Industrial Company Limited Procede de production de derives de 3-chloromethyl-3-cepheme

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (fr) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Composés polyazathia, procédé pour leur préparation, compositions pharmaceutiques les contenant et utilisation de ces dernières
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (fr) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (fr) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
KR850007424A (ko) 1985-12-04
SE8901226D0 (sv) 1989-04-06
IL74826A (en) 1990-01-18
JPH0350754B2 (fr) 1991-08-02
FI84830C (fi) 1992-01-27
IT8520267A0 (it) 1985-04-05
GB2157293A (en) 1985-10-23
GB2194789B (en) 1988-10-12
GB2194789A (en) 1988-03-16
SE470260B (sv) 1993-12-20
AU610278B2 (en) 1991-05-16
SE505256C2 (sv) 1997-07-21
SU1436882A3 (ru) 1988-11-07
DE3512225A1 (de) 1985-10-17
NL192925B (nl) 1998-01-05
KR870002166B1 (ko) 1987-12-14
SE466205B (sv) 1992-01-13
JPS615084A (ja) 1986-01-10
YU46213B (sh) 1993-05-28
SU1375140A3 (ru) 1988-02-15
JPS61143390A (ja) 1986-07-01
CA1276929C (fr) 1990-11-27
IE58403B1 (en) 1993-09-22
ES551550A0 (es) 1987-06-01
AU580990B2 (en) 1989-02-09
AU4086285A (en) 1985-10-17
YU46151B (sh) 1993-05-28
ES551551A0 (es) 1987-07-01
DD251752A5 (de) 1987-11-25
JPS61143387A (ja) 1986-07-01
JPS61143391A (ja) 1986-07-01
ES8706155A1 (es) 1987-06-01
DD249024A5 (de) 1987-08-26
SU1367858A3 (ru) 1988-01-15
YU118987A (en) 1988-10-31
IE58408B1 (en) 1993-09-22
GB2194790A (en) 1988-03-16
HU204277B (en) 1991-12-30
GB2157293B (en) 1988-10-05
SE8901225D0 (sv) 1989-04-06
PT80246B (pt) 1987-10-20
ATA103985A (de) 1989-01-15
JPH0351716B2 (fr) 1991-08-07
ZA852236B (en) 1985-11-27
FI851379A0 (fi) 1985-04-04
FI84830B (fi) 1991-10-15
SU1487814A3 (ru) 1989-06-15
CH669197A5 (de) 1989-02-28
GB8508846D0 (en) 1985-05-09
SE8901224D0 (sv) 1989-04-06
JPH0262557B2 (fr) 1990-12-26
SE8501680L (sv) 1985-10-10
IE850866L (en) 1985-10-09
NL8501002A (nl) 1985-11-01
AR244694A1 (es) 1993-11-30
DK155985A (da) 1985-10-10
MY101940A (en) 1992-02-15
SE8901225L (sv) 1989-04-06
HU193750B (en) 1987-11-30
SE470259B (sv) 1993-12-20
AT388735B (de) 1989-08-25
GR850883B (fr) 1985-11-25
SE8901224L (sv) 1989-04-06
NZ211659A (en) 1988-11-29
IT1190353B (it) 1988-02-16
OA07985A (fr) 1987-01-31
YU60085A (en) 1987-12-31
HUT37622A (en) 1986-01-23
AU2504188A (en) 1989-03-02
ES542013A0 (es) 1986-06-16
LU85840A1 (fr) 1985-12-16
DD236735A5 (de) 1986-06-18
ES8800949A1 (es) 1987-12-01
PT80246A (en) 1985-05-01
SE8501680D0 (sv) 1985-04-03
ES8607318A1 (es) 1986-06-16
JPH0357106B2 (fr) 1991-08-30
RU2056425C1 (ru) 1996-03-20
FR2563832A1 (fr) 1985-11-08
ES8706694A1 (es) 1987-07-01
NL192925C (nl) 1998-05-07
DK155985D0 (da) 1985-04-03
GB2194790B (en) 1988-10-05
ES557060A0 (es) 1987-12-01
FR2563832B1 (fr) 1989-08-18
GB8721346D0 (en) 1987-10-14
BE902148A (fr) 1985-10-09
CA1340638C (fr) 1999-07-06
FI851379L (fi) 1985-10-10
DE3512225C2 (fr) 1990-02-22
GB8721347D0 (en) 1987-10-14
IL74826A0 (en) 1985-07-31
SE8901226L (sv) 1989-04-06

Similar Documents

Publication Publication Date Title
CA1340672C (fr) Derives de la cephalosporine
US4839350A (en) Cephalosporin compounds and the production thereof
US5244890A (en) Cephem compounds
US4487767A (en) 7-[Amino or carboxy substituted oxyimino]-3-[amino or alkoxy substituted heterocyclic thiomethyl] cephalosporin derivatives
US4943567A (en) Cephalosporin compound and pharmaceutical composition thereof
US4751295A (en) Cephalosporin derivatives
US4703046A (en) Cephem compounds and processes for preparation thereof
JPH0723380B2 (ja) 新規セフェム化合物
JPS5932475B2 (ja) 2−アルキル−7−置換−2もしくは3−セフエム−4−カルボン酸化合物類およびその塩類およびそれらの製造法
US4988686A (en) Cephem compounds and anti-bacterial agent
CA1340609C (fr) Derives de la cephalosporine
US4687769A (en) 3-(3,3,3-trifluoropropenyl) cephalosporins
US4350694A (en) Cephalosporin analogues and antimicrobial compositions
JPH0364503B2 (fr)
US4761409A (en) Cephem derivatives
GB2034692A (en) New cephem compounds and processes for preparation thereof
US4408042A (en) Cephem compounds
JPH035486A (ja) チアゾリルアセトアミドセフェム誘導体
JPS6127991A (ja) セフアロスポリン誘導体その製造法およびそれを有効成分とする抗菌剤
CZ286386B6 (cs) 3-Cefem-4-karboxylátové deriváty, způsob jejich přípravy, a farmaceutický prostředek, který je obsahuje
JPS62228084A (ja) セフアロスポリン誘導体
JPS6388187A (ja) 3−アンモニオプロペニルセフエム誘導体
JPH06306081A (ja) 新規セフェム化合物
JPH0240073B2 (ja) Shinkisefuarosuhorinkagobutsuoyobisoreojukoseibuntosurukokinzai

Legal Events

Date Code Title Description
MKLA Lapsed